jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmacy PracticeNOW IN
Review

Current Status of Adverse Drug Reactions Monitoring Centres under Pharmacovigilance Programme of India

V Kalaiselvan1★, Prasad Thota1, Abishank Singh2★ Corresponding author

  1. 1Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, Sector 23, Rajnagar, Ghaziabad 201002 (U.P), India.
  2. 2Faculty of Pharmacy, Jamia Hamdard, Deemed University, Hamdard Nagar, New Delhi 110 062, India.

CORRESPONDENCE

V Kalaiselvan

Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, Sector 23, Rajnagar, Ghaziabad 201002 (U.P), India.

vivekarts@rediffmail.com

Received: 03-04-2014; Accepted: 04-09-2014.

Volume 7, Issue 3 · pp. 19–22 · PUBLISHED · DOI: 10.5530/ijopp.7.3.5

View on IJPP original site ↗

ABSTRACT

There are one hundred and fifty Adverse Drug Reactions Monitoring Centres (AMCs) across the country are functioning and reporting’s Adverse Drug Reactions to National Coordination centre (NCC), Pharmacovigilance Programme of India (PvPI) at Indian Pharmacopoeia Commission (IPC), Ghaziabad. The AMCs are established to collate data on Pharmacovigilance and forward to NCC via online software (VigiFlow). The present AMCs are Medical Council of India (MCI) approved teaching hospitals and corporate hospitals. NCC is working with AMCs to coordinate with Pharmacy institutions to enhance ADRs reporting.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Kalaiselvan, V., Thota, P., & Singh, A. (). Current Status of Adverse Drug Reactions Monitoring Centres under Pharmacovigilance Programme of India. Indian Journal of Pharmacy Practice, 7(3), 19–22. https://doi.org/10.5530/ijopp.7.3.5